Vallabh Janardhan: Thrombectomy Has Transformed What Is Possible for Patients with Life-Threatening Vascular Emergencies
Vallabh Janardhan, Co-Founder and CMO at Insera Therapeutics, Inc., shared on LinkedIn:
”Today is World Thrombectomy Day.
Thrombectomy refers to minimally invasive catheter-based procedures designed to remove blood clots from blood vessels and restore blood flow.
Over the last decade, thrombectomy has transformed what is possible for patients suffering from stroke and other life-threatening vascular emergencies including pulmonary embolism, deep vein thrombosis, acute limb ischemia, thrombosed dialysis access, and even certain forms of heart attack.
What once often resulted in devastating disability, limb loss, or death can now, in many cases, be treated through rapid image-guided intervention with remarkable recovery.
But successful thrombectomy begins long before the angio suite.
It begins with:
- awareness
- rapid recognition
- EMS activation
- transport coordination
- imaging
- emergency teams
- nurses, technologists, physicians, and multidisciplinary systems all moving together against time
One of the greatest privileges of my career has been working alongside extraordinary teams committed to advancing systems of care and improving access to life-saving intervention.
Breakthrough technology only changes outcomes when combined with great teams and coordinated systems of care.
Grateful to all the EMS professionals, nurses, physicians, technologists, hospital administrators, researchers, healthcare and medtech investors, innovators, professional societies, industry partners, healthcare systems, patients, and families advancing thrombectomy care around the world every single day.”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series